The Medicines Company Saves Lives With Angiomax
The Medicines Co. (MDCO) is carving its niche with products that hospitals depend on for critical care and coronary interventions. The Medicines Co.'s Angiomax drug -- which accounts for almost all its sales -- is an anticoagulant for patients with unstable angina undergoing coronary angioplasty procedures. Its Cleviprex product is an intravenous small molecule calcium channel blocker to reduce blood pressure. It's also used to treat
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here